A new method for detecting and quantifying minute amounts of a biomarker of Parkinson’s and related diseases could open up opportunity for much-needed early pre-symptomatic diagnosis. Haley Bridger, Brigham and Women’s Hospital communications, and Benjamin Boettner, Wyss Institute communications, report.
A new European research project called BE-LIGHT has received €2.5 million in funding from the EU’s Horizon Europe programme to develop new photonics and AI tools for the early detection and treatment of ocular, cardiovascular and neurodegenerative diseases. The project is coordinated by the Centre for Sensors, Instruments and Systems Development (CD6) at Universitat Politècnica […]
A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine [1]. The results of the studies indicate that the PET imaging agent may be a promising theranostic candidate […]
In a world-first, a full-body MRI scanner for real-time imaging has been combined with a proton therapy system to provide a scientific prototype for MRI-guided proton therapy. With this installation in Dresden, Germany, experts from the fields of medicine, medical physics, biology and engineering are embarking on the scientific testing of a new form of […]
A major clinical trial has shown that by using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression, patients will see their symptoms ease for at least six months, which could vastly improve their quality of life.
Scientists at the Georgia Tech Integrated Cancer Research Center (ICRC) have combined machine learning with information on blood metabolites to develop a new test able to detect ovarian cancer with 93 percent accuracy among samples from the team’s study group.
The World Health Organization (WHO) is releasing new guidance on the ethics and governance of large multi-modal models (LMMs) – a type of fast growing generative artificial intelligence (AI) technology with applications across health care.
Using a type of deep learning artificial intelligence, researchers at the Wyss Institute and MIT have discovered a class of compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium that causes many deaths around the world every year.
Healthcare 21 Group (HC21) will be at Arab Health 2024 to showcase their specialist support services designed to help international MedTech manufacturers navigate the UK market with confidence.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.